The purchase fits Merck's plans to partly focus on acute care in hospitals. Cubist's lead drugs treats infections caused by drug-resistant bacteria. Fred Katayama reports.
00:49
01:03
02:02
00:47
01:37
02:46
01:05
00:41
00:57
01:50
00:45
00:45
01:00
02:07
00:52
01:13
01:13
00:36
02:00
01:28
01:21
00:36
01:52
01:52
00:47
01:44
02:15
02:15
01:29
00:41
01:19
00:55
01:33
02:12
01:50
00:45
02:35
00:31
00:31
01:28
01:03
01:50
00:45
00:45
01:49
01:06
01:49
01:04
01:30
01:04
00:55
01:19
01:19
01:29
01:52
01:27
01:15
00:49
00:35
01:36
01:56
01:45
01:25
01:19
01:41
01:00
00:40
01:46
00:55
00:31
01:45
00:58
00:38
00:45
01:06
01:16
01:01
01:17
00:54
00:51
01:56
02:04
02:07
01:48
02:03
01:43
02:01
01:31
01:08
00:54
01:14
01:19
01:33
01:37
01:48
01:38
00:47
03:31
01:08
00:49